Evidence map›Paper›PMID 39078330›Full record

ReviewTissue engineering. Part B, Reviews2025

Magnetic Cell Targeting for Cardiovascular Tissue Engineering.

Akankshya Shradhanjali, Jayne T Wolfe, Brandon J Tefft

Abstract readReview
In one paragraph

Review in Tissue engineering. Part B, Reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akankshya ShradhanjaliJoint Department of Biomedical Engineering, Medical College of Wisconsin & Marquette University, Milwaukee, Wisconsin, USA.
Jayne T WolfeJoint Department of Biomedical Engineering, Medical College of Wisconsin & Marquette University, Milwaukee, Wisconsin, USA.
Brandon J TefftJoint Department of Biomedical Engineering, Medical College of Wisconsin & Marquette University, Milwaukee, Wisconsin, USA.ORCID 0000-0003-3687-7093

Funding

Nanotechnology for Magnetic Endothelialization of Implantable Cardiovascular DevicesR00HL129068 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI TEFFT, BRANDON J · 2018 to 2020
$737k
NHLBI NIH HHS R00 HL129068
6 · The paper itself

Abstract

There is a critical need for novel approaches to translate cell therapy and regenerative medicine to clinical practice. Magnetic cell targeting with site specificity has started to open avenues in these fields as a potential therapeutic platform. Magnetic targeting is gaining popularity in the field of biomedicine due to its ability to concentrate and retain at a target site while minimizing deleterious effects at off-target sites. It is regarded as a relatively straightforward and safe approach for a wide range of therapeutic applications. This review discusses the latest advancements and approaches in magnetic cell targeting using endocytosed and surface-bound magnetic nanoparticles as well as

Indexed as

Cardiovascular SystemMagnetite NanoparticlesTissue EngineeringAnimalsHumansMagnetite Nanoparticlesantibody-conjugationcardiovascular diseasemagnetic cell targetingMRI trackingregenerative medicineSPIONsuperparamagnetic iron oxide nanoparticles

Identifiers

PMID39078330
PMCPMC12223378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.